Tissue Repair (ASX:TRP) Revenue: A$0.53 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:TRP Tissue Repair Ltd ASX:TRP
26 GF Score
Price A$0.11
View Full Analysis

What is Tissue Repair Revenue?

Tissue Repair ASX:TRP 26 Revenue is A$0.53 Mil as of Dec. 2025. GuruFocus rates ASX:TRP with a GF Score™ of 26/100.

Tissue Repair's revenue for the six months ended in Dec. 2025 was A$0.31 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.53 Mil. Tissue Repair's Revenue per Share for the six months ended in Dec. 2025 was A$0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Tissue Repair was 125.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Tissue Repair  (ASX:TRP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Tissue Repair Revenue Related Terms

Tissue Repair Revenue Historical Data

* Premium members only.

The historical data trend for Tissue Repair's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair Revenue Chart

Tissue Repair Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Revenue
0.00 0.00 0.00 0.15 0.42

Tissue Repair Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.09 0.20 0.23 0.31

ASX:TRP vs VRTX, REGN, ALNY: Revenue Comparison

For the Biotechnology subindustry, Tissue Repair's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Repair Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Repair's Revenue distribution charts can be found below:

* The bar in red indicates where Tissue Repair's Revenue falls into.


ASX:TRP
26GF Score
Tissue Repair Ltd ASX:TRP
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Repair Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of A$0.53 Mil mean?
Tissue Repair (ASX:TRP) has a Revenue of A$0.53 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Tissue Repair and its competitors.
Is Tissue Repair's Revenue too high?
Tissue Repair's current Revenue is A$0.53 Mil. Overall, Tissue Repair has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's Revenue compare to VRTX and REGN?
Tissue Repair's Revenue of A$0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Tissue Repair and its competitors. Tissue Repair's current Revenue is A$0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current Revenue of A$0.53 Mil. The current Revenue is A$0.53 Mil. Tissue Repair's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current Revenue is A$0.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Repair Business Description

Address 821 Pacific Highway, Tower A, Level 9, The Zenith, Chatswood, NSW, AUS, 2067
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
26GF Score

Get the complete analysis for ASX:TRP

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price